Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 - New Report by MarketsandMarkets

Rising incidence of other chronic diseases, aging population, and increasing healthcare spending will aid the growth of the global tissue diagnostics market - http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
MarketsandMarkets

MarketsandMarkets

Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.). Other important players in this market are Biogenex Laboratories (U.S.), Sigma-Aldrich (U.S.), Cell Signaling Technology (U.S.), Bio SB (U.S.)

(PRWEB) July 29, 2014

The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The Americas, Europe, BRIC, Japan & RoW) - Trends & Forecast to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global tissue diagnostics market along with the estimates and forecasts of the revenue and share analysis.

The global tissue diagnostics market is expected to grow at a CAGR of close to 6.97% between 2013 and 2018, to reach $3,924.01 million by 2018.

For Further Inquiries: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1063949

According to GLOBOCAN, about 14.1 million new cancer cases and 8.2 million cancer-related deaths were recorded globally in 2012. Based on GLOBOCAN’s statistics, the International Agency for Research on Cancer (ICRA) and the World Health Organization (WHO) have estimated that by 2025, around 19.3 million new cancer cases are expected to occur per year. Tissue diagnostic tests are primarily used for screening, diagnosis, determining the prognosis, and monitoring the response to the therapy for cancer. Rising incidence of other chronic diseases, aging population, and increasing healthcare spending will aid the growth of the global tissue diagnostics market. Furthermore, the Patient Protection and Affordable Care Act (PPACA) introduced in the U.S. in March 2010 is expected to expand the insurance access to more than 30 million U.S. citizens. This is expected to drive the demand for advanced cancer diagnostics, including tissue diagnostics, in this important geographic segment.

The tissue diagnostics market includes a number of highly specialized diagnostic tests based on immunohistochemistry, in situ hybridization, and special staining. This market includes instruments and consumables for each of these diagnostic procedures. Furthermore, there are separate and highly specific test kits which are based on multiple markers for different types of cancers. These test kits depend on the large number and patterns of multiple cell surface markers to identify cancer cells and differentiate between different types of cancer cells. As such, these test kits allow for identification of not just the type, but also the stage and prognosis of multiple types of cancers. Furthermore, tissue diagnostic-based products are also being used as companion diagnostics for identifying treatment-responsive clinical trial candidates for investigational drug products. With a large number of products present in the tissue diagnostics market, it becomes important to identify the current market size and future market potential for each of them. This information will enable market players make well informed decisions about growth strategies in this highly competitive and rapidly evolving market.

Request for customization of report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=1063949.

Organizational diagnostics market, including immunohistochemistry and in situ hybridization, special staining based on a number of professional diagnostic tests. This market includes tools and supplies in each diagnostic method. In addition, the number of marks as there is different types of cancer with high specificity, respectively, based on a detection kit. Testing of these groups will depend on a large number of surface markers used to identify a pattern and some tumor cells and various types of differentiated cells in the tumor cells. Therefore, these test kits allow the identification of not only the type, but there are also staging and prognosis of many types of cancer. Moreover, according to the organization's diagnostic products are also being used as a diagnostic to identify response processing associated with the study drug candidates in clinical trials. Due to a large number of diagnostic tissue products on the market becomes very important to determine each of them market the current market size and growth potential. This information will allow market participants to decide in this highly competitive and rapidly changing market of the future strategy of fully informed.

Based on geography, the global tissue diagnostics market is segmented into the Americas, Europe, BRIC, Japan, and the Rest of the World (RoW). The Americas is further divided into regional segments, such as U.S., Canada, Mexico, Chile, and the Rest of the Americas. The Europe segment is further divided into the regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The BRIC segment includes the regional segments of Brazil, Russia, India, and China.

The major players in the tissue diagnostics market are Agilent Technologies (U.S.), Abbott Laboratories (U.S.), Bio SB (U.S.), Biogenex Laboratories (U.S.), Cell Signaling Technology (U.S.), Danaher Corporation (U.S.), Life Technologies (U.S.), Roche Diagnostics (Switzerland), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific (U.S.).

Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html

Point-Of-Care Diagnostics/Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices.
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets.


Contact